-2.4%
TJX vs MRNA
+909.7%
-912.0%
-26.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.3% | -6.5% | +2.3% | -4.3% |
| 7D | -2.0% | +8.4% | -10.4% | -1.9% |
| 30D | +1.1% | +28.8% | -27.7% | +1.6% |
| 3M | -13.1% | +329.2% | -342.3% | -9.7% |
| 6M | -10.0% | +416.9% | -426.9% | -7.7% |
| YTD | -8.9% | +718.8% | -727.7% | -8.3% |
| 1Y | -2.4% | +924.9% | -927.3% | -2.8% |
| All | -2.4% | +909.7% | -912.0% | -2.8% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling